Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT02768298
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT02768298 -
2015-004632-35
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02768298. Randomized; double masking; primary purpose treatment. Start 2016-07-12 (actual); primary completion 2019-11-25 (actual). Results posted on 2020-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
- Condition
- Chronic Heart Failure With Reduced Ejection Fraction
- Intervention (Drug)
- LCZ696
- Intervention (Drug)
- Enalapril
- Intervention (Drug)
- Placebo matching enalapril
- Intervention (Drug)
- Placebo matching LCZ696
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct02768298- Content hash
024f8e2b0a8750f656a7499b2f7f65ca43e375c93b1889d510c171de8bd23b24